Detalhe da pesquisa
1.
Noncoding mutations drive persistence of a founder preleukemic clone which initiates late relapse in T-ALL.
Blood
; 143(10): 933-937, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194681
2.
Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia.
Blood
; 140(1): 25-37, 2022 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35507686
3.
Restoration of Foxp3+ Regulatory T Cells by HDAC-Dependent Epigenetic Modulation Plays a Pivotal Role in Resolving Pulmonary Arterial Hypertension Pathology.
Am J Respir Crit Care Med
; 208(8): 879-895, 2023 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676930
4.
Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia.
Blood
; 129(24): 3221-3226, 2017 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28270453
5.
Prognostic impact of the absence of biallelic deletion at the TRG locus for pediatric patients with T-cell acute lymphoblastic leukemia treated on the Medical Research Council UK Acute Lymphoblastic Leukemia 2003 trial.
Haematologica
; 103(7): e288-e292, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29519867
6.
The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia.
J Clin Oncol
; 41(19): 3545-3556, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37098241
7.
EZH2-Deficient T-cell Acute Lymphoblastic Leukemia Is Sensitized to CHK1 Inhibition through Enhanced Replication Stress.
Cancer Discov
; 10(7): 998-1017, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32349972
8.
The role of noncoding mutations in blood cancers.
Dis Model Mech
; 12(11)2019 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31771951
9.
JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemia.
J Exp Med
; 215(7): 1929-1945, 2018 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29941549
10.
Corrigendum: Small genomic insertions form enhancers that misregulate oncogenes.
Nat Commun
; 8: 15797, 2017 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28569765
11.
Small genomic insertions form enhancers that misregulate oncogenes.
Nat Commun
; 8: 14385, 2017 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28181482
12.
Synergy between histone deacetylase inhibitors and DNA-damaging agents is mediated by histone deacetylase 2 in colorectal cancer.
Oncotarget
; 7(28): 44505-44521, 2016 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27283986
13.
E2F1-mediated FOS induction in arsenic trioxide-induced cellular transformation: effects of global H3K9 hypoacetylation and promoter-specific hyperacetylation in vitro.
Environ Health Perspect
; 123(5): 484-92, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25574600
14.
PGC-1α controls mitochondrial biogenesis and dynamics in lead-induced neurotoxicity.
Aging (Albany NY)
; 7(9): 629-47, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26363853
15.
Erratum: PGC-1α controls mitochondrial biogenesis and dynamics in lead-induced neurotoxicity.
Aging (Albany NY)
; 8(4): 832, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27182745
16.
Erratum: PGC-1α controls mitochondrial biogenesis and dynamics in lead-induced neurotoxicity.
Aging (Albany NY)
; 7(11): 1023, 2015 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30344185